Piper Jaffray Starts Par Pharmaceutical (PRX) at Overweight
Tweet Send to a FriendGet Alerts PRX Hot Sheet
Price: $49.98 --0%
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade PRX Now!
Piper Jaffray initiates coverage on Par Pharmaceutical (NYSE: PRX) with an Overweight. PT $49.00.
For an analyst ratings summary and ratings history on Par Pharmaceutical click here. For more ratings news on Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $40.20 yesterday, with a 52 week range of $24.85-$41.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Par Pharmaceutical click here. For more ratings news on Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $40.20 yesterday, with a 52 week range of $24.85-$41.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Topeka Capital Starts CEVA Inc. (CEVA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper Jaffray
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
